Medicine News and Research

RSS

Poop pills could help cancer patients respond to immunotherapy while reducing toxic side effects

Fecal microbiota transplants (FMT), can dramatically improve cancer treatment, suggest two groundbreaking studies published in the prestigious Nature Medicine journal.

28 Jan 2026

Four-biomarker blood panel enhances the detection of pancreatic ductal adenocarcinoma

A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and thrombospondin-2 (THBS2) enhanced the detection of pancreatic ductal adenocarcinoma (PDAC) compared to measuring CA19-9 levels alone.

28 Jan 2026

Mapping the early onset of coronary heart disease in men

Men begin developing coronary heart disease - which can lead to heart attacks - years earlier than women, with differences emerging as early as the mid-30s, according to a large, long-term study led by Northwestern Medicine.

28 Jan 2026

New peptide targets the root causes of recurring seizures

New study suggests that an experimental peptide developed at the Hebrew University may reduce recurring seizures and support brain function by targeting underlying oxidative stress and inflammation processes linked to epilepsy.

28 Jan 2026

Men still develop heart disease 10 years earlier than women

Historical data indicate that men develop coronary heart disease (CHD) 10 years before women. A recent study in the Journal of the American Heart Association indicates that this sex gap still remains.

28 Jan 2026

Nudges to clinicians and patients increase the rate of influenza vaccination

Patients were 28 percent more likely to get a flu shot when they got a text message reminder and their primary care provider already had an order for the shot waiting, new research from the Perelman School of Medicine showed.

28 Jan 2026

New discovery may aid in early detection of rare genetic disease

Virginia Tech researchers discovered an indication hidden in the brain that may help doctors identify children suffering from a rare genetic disease earlier. Their findings were published recently in EMBO Molecular Medicine.

28 Jan 2026

Color vision deficiency is linked to worse survival in bladder cancer

The study highlights how color vision deficiency can delay bladder cancer diagnosis, increasing mortality risk and underscoring the need for targeted screening.

28 Jan 2026

Transcranial magnetic stimulation can be a cost-effective treatment option for depression

A major new study has found that transcranial magnetic stimulation (TMS), which applies magnetic energy to the brain, can be a cost-effective treatment option for the NHS in treating moderate and severe forms of depression that have not responded to other treatments.

27 Jan 2026

Clinical trial aims to improve survival for patients with recurrent head and neck cancer

A newly approved National Cancer Institute-funded clinical trial aims to improve survival for head and neck cancer patients whose disease returns after radiation therapy – a setback that affects up to 40% of patients and is often associated with poor outcomes.

27 Jan 2026

First topical CRISPR gene therapy corrects disease-causing mutations in human skin

Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the University of British Columbia are extending those possibilities to the skin for the first time.

27 Jan 2026

Depression and anxiety together raise long COVID risk in older women

Older women who have a history of both depression and anxiety had a 78% higher risk of developing long COVID after a SARS-CoV-2 infection, report University of California San Diego researchers in the Jan. 27, 2026 online edition of the journal Menopause.

27 Jan 2026

Antibody-producing plasma cells shape effectiveness of PD-1 immunotherapy

Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps explain why some cancer patients benefit from immunotherapy while others do not.

27 Jan 2026

Overactive protein cleanup disrupts nuclear pores in neurodegenerative disease

When it comes to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and certain forms of dementia, researchers have known that protein quality control and damage to the nuclear pore are key players.

27 Jan 2026

Immune system dysfunction may fuel progressive heart failure after heart attacks

When the heart's muscle is weakened or injured due to a heart attack, it can make it hard for the heart to pump enough blood to meet the body's needs.

27 Jan 2026

MRI measures of glymphatic activity may improve noninvasive intracranial hypertension diagnosis

A new study led by investigators from Mass General Brigham shows that a brain waste- "clean-up" system is influenced by intracranial pressure.

27 Jan 2026

Study reveals heart, brain, neuroimmune connections driving damage after heart attacks

Arteries become clogged. Blood flow is restricted and oxygen is cut off. The result is a heart attack, the world's leading cause of death.

27 Jan 2026

Insilico Medicine and Qilu Pharmaceutical partner to develop AI-designed cardiometabolic drugs

Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its subsidiary Shanghai Qilu Pharmaceutical Research Center, today announced a strategic partnership on innovative drug development, leveraging Insilico's proprietary Pharma.AI platform to jointly develop small molecule inhibitors, focusing on specific targets for cardiometabolic disease management.

27 Jan 2026

PFOA exposure disrupts hormone signaling and impairs embryo implantation in mice

A new experimental study has found that perfluorooctanoic acid (PFOA), a widely used industrial chemical, can interfere with key biological processes required for successful embryo implantation, raising concerns about its potential impact on female fertility.

27 Jan 2026

Gut problems may shape Parkinson’s disease progression through the gut-brain axis

This narrative review examines how gastrointestinal dysfunction, gut dysbiosis, and altered gut-brain axis signaling are closely associated with the onset and progression of Parkinson’s disease. It synthesizes evidence supporting a possible bottom-up disease model while highlighting integrative, gut-targeted strategies as adjuncts to symptom management rather than proven disease-modifying therapies.

27 Jan 2026

Medicine News and Research

Poop pills could help cancer patients respond to immunotherapy while reducing toxic side effects

Four-biomarker blood panel enhances the detection of pancreatic ductal adenocarcinoma

Mapping the early onset of coronary heart disease in men

New peptide targets the root causes of recurring seizures

Men still develop heart disease 10 years earlier than women

Nudges to clinicians and patients increase the rate of influenza vaccination

New discovery may aid in early detection of rare genetic disease

Color vision deficiency is linked to worse survival in bladder cancer

Transcranial magnetic stimulation can be a cost-effective treatment option for depression

Clinical trial aims to improve survival for patients with recurrent head and neck cancer

First topical CRISPR gene therapy corrects disease-causing mutations in human skin

Depression and anxiety together raise long COVID risk in older women

Antibody-producing plasma cells shape effectiveness of PD-1 immunotherapy

Overactive protein cleanup disrupts nuclear pores in neurodegenerative disease

Immune system dysfunction may fuel progressive heart failure after heart attacks

MRI measures of glymphatic activity may improve noninvasive intracranial hypertension diagnosis

Study reveals heart, brain, neuroimmune connections driving damage after heart attacks

Insilico Medicine and Qilu Pharmaceutical partner to develop AI-designed cardiometabolic drugs

PFOA exposure disrupts hormone signaling and impairs embryo implantation in mice

Gut problems may shape Parkinson’s disease progression through the gut-brain axis

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News